Pds biotech to present at btig virtual biotechnology conference 2023

Princeton, n.j., aug. 02, 2023 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the company's proprietary t cell activating platforms, today announced that dr. frank bedu-addo, chief executive officer, will participate in a fireside chat at the btig virtual biotechnology conference 2023 being held august 7-8, 2023. details for the event are as follows:
PDSB Ratings Summary
PDSB Quant Ranking